Cytotoxicity of a titanium alloy coated with hydroxyapatite by plasma jet deposition
Abstract
Background/Aim. The deposition of hydroxyapatite (HAP) on the surface of titanium (Ti) alloys enhances bioactivity and osseointegration of the alloys which are widely used as implant materials in dentistry and orthopaedic surgery. However, the stability of HAP and subsequent biocompatibility of such alloys depends on the coating technique. The aim of this work was to test the cytotoxicity of a Ti alloy (Ti6Al4V), coated with HAP by a new plasma deposition method. Methods. The Ti6Al4V samples prepared as discs, 10 mm in diameter and 2 mm in thickness, were coated with HAP (one or both sides of the alloy) by an innovative atmospheric plasma jet method. The cytotoxicity of uncoated and HAP coated Ti6Al4V samples was evaluated by examining the morphological changes and viability of L929 fibroblasts in direct contact with the test materials. Adequate negative (polystyrene) and positive (nickel) control discs of the same size were used. The indirect cytotoxicity was determined by cultivating L929 cells with conditioning medium (CM), prepared as extract of the test samples incubated in the complete Roswell Park Memorial Institute (RPMI) 1640 medium for cell cultures. The cytotoxic effect was evaluated based on the degree of metabolic activity, necrosis, apoptosis and proliferation of L929 cells, using the appropriate assays. Results. Uncoated and one side HAP coated Ti6Al4V alloys were classified as non-cytotoxic according to the current ISO 10993-5 criteria, whereas two sides HAP coated Ti6Al4V alloy samples were slightly-moderate cytotoxic. The cytotoxicity manifested as the inhibition of metabolic activity and proliferation of L929 cells as well as the induction of their apoptosis and necrosis was significantly reduced by conditioning of HAP/Ti6Al4V alloys for 24 hours. The cytotoxic effect of HAP/Ti6Al4V CM only partly decreased in the presence of nifelate, a calcium (Ca) channel blocker, suggesting that Ca ions were not the only responsible cytotoxic agent. Conclusion. The original HAP coating procedure by atmospheric plasma spraying with high energy input enables the production of the stable adhesive coatings on Ti6Al4V alloys. Their cytotoxicity, which depends on the quantity of HAP coating layer, could be significantly reduced up to the non-cytotoxic level by prior conditioning of the alloys in culture medium. Such a procedure, which removes leachable toxic components, could be useful before implantation of HAP coated alloys in vivo.
References
Okazaki Y, Rao S, Ito Y, Tateishi T. Corrosion resistance, me-chanical properties, corrosion fatigue strength and cytocom-patibility of new Ti alloys without Al and V. Biomaterials 1998; 19(13): 1197‒215.
Fojt J, Joska L, Malek J. Corrosion behaviour of porous Ti–39Nb alloy for biomedical applications. Corr Sci 2013; 71: 78–83.
Geetha M, Singh AK, Asokamani R, Gogia AK. Ti based bio-mate¬rials, the ultimate choice for orthopaedic implants – A review. Prog Mater Sci 2009; 54(3): 397‒425.
Upadhyay D, Panchal MA, Dubey RS, Srivastava VK. Corrosion of alloys used in dentistry: A review. Mater Sci Eng A 2006; 432: 1–11.
Bral A, Mommaerts MY. In vivo biofunctionalization of tita-nium patient-specific implants with nano hydroxyapatite and other nano calcium phosphate coatings: A systematic review. J Craniomaxillofacial Surg 2016; 44(4): 400‒12.
Palanivelu R, Kalainathan S, Kumar AR. Characterization stud-ies on plasma sprayed (AT/HA) bi-layered nano ceramics coating on biomedical commercially pure titanium dental im-plant. Ce¬ram Int 2014; 40: 7745‒51.
Drevet R, Viteaux A, Maurin JC, Benhayoune H. Human os-teoblast-like cells response to pulsed electrodeposited calcium phosphate coatings. RSC Advances 2013; 3(28): 11148‒54.
Urquia Edreira ER, Wolke JG, Al Farraj Aldosari A, Al-Johany SS, Anil S, Jansen JA, et al. Effects of calcium phosphate com-position in sputter coatings on in vitro and in vivo perform-ance. J Biomed Mater Res A 2015; 103(1): 300‒10.
Goodman SB, Yao Z, Keeney M, Yang MF. The future of biologic coatings for orthopaedic implants. Biomaterials 2013; 34(13): 3174‒83.
Zhang BG, Myers DE, Wallace GG, Brandt M, Choong PF. Bio-ac¬tive coatings for orthopaedic implants - Recent trends in de-velopment of implant coatings. Int J Mol Sci 2014; 15(7): 11878–921.
Mohseni E, Zalnezhad E, Bushroa AR. Comparative investiga-tion on the adhesion of hydroxyapatite coating on Ti–6Al–4V im¬plant: A review paper. Int. J Adhes Adhes 2014, 48: 238–57.
Maxian SH, Zawadsk JP, Dunn MG. Mechanical and histologi-cal evaluation of amorphous calcium phosphate and poorly crystallized hydroxyapatite coatings on titanium implants. J Biomed Mater Res 1993; 27(6): 17–28.
Jokanović V, Vilotijević M, Čolović B, Jenko M, Anžel I, Rudolf R. Enhanced adhesion properties, structure and sintering mecha-nism of hydroxyapatite coatings obtained by plasma jet depo-sition. Plasma Chem Plasma Process 2015; 35: 1‒19.
International Standards Organization. ISO10993-5: Biological evaluation of medical devices, part 5. Geneva: ISO; 2009.
Sieuwerts AM, Klijn JG, Peters HA, Foekens JA. The MTT tetra-zolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the as-sessment of growth characteristics, IC50-values and cell sur-vival. Eur J Clin Chem Clin Biochem 1995; 33(11): 813‒23.
Čolić M, Gasić S, Vucević D, Pavicić L, Popović P, Jandrić D et al. Modulatory effect of 7-thia-8-oxoguanosine on proliferation of rat thymocytes in vitro stimulated with concanavalin A. Int J Immunopharmacol. 2000; 22(3): 203‒12.
Hannon P. A brief review of current orthopedic implant device issues: biomechanics and biocompatibility. Biol End Med 2016; 1(1): 1‒2.
Mohseni E, Zalnezhad E, Bushroa AR. Comparative investiga-tion on the adhesion of hydroxyapatite coating on Ti–6Al–4V im¬plant: A review paper. Int J Adhes 2014; 48: 238–57.
Maxian SH, Zawadsk JP, Dunn MG. Mechanical and histologi-cal evaluation of amorphous calcium phosphate and poorly crystallized hydroxyapatite coatings on titanium implants. J Biomed Mater Res 1993; 27(6): 717–28.
Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185(8): 1481‒6.
Li Y, Wong C, Xiong J, Hodgson P, Wen C. Cytotoxicity of tita-nium and titanium alloying elements. J Dent Res 2010; 89(5): 493‒7.
Sidambe AT. Biocompatibility of Advanced Manufactured Ti-ta¬nium Implants—A Review. Materials 2014; 7(12): 8168‒88.
Chandar S, Kotian R, Madhyastha P, Kabekkodu SP, Rao P. In vi-tro evaluation of cytotoxicity and corrosion behavior of com-mercially pure titanium and Ti-6Al-4V alloy for dental im-plants. J Indian Prosthodont Soc 2017; 17(1): 35‒40.
Yuan Y, Liu C, Qian J, Wang J, Zhang Y. Size-mediated cyto-toxic¬ity and apoptosis of hydroxyapatite nanoparticles in hu-man hepatoma HepG2 cells. Biomaterials 2010; 31(4): 730‒40.
Rahman ZU, Shabib I, Haider W. Rahman ZU, Shabib I, Haider W. Surface characterization and cytotoxicity analysis of plasma sprayed coatings on titanium alloys. Mater Sci Eng C Mater Biol Appl 2016; 67: 675‒83.
Radin SR, Ducheyne P. The effect of calcium phosphate ceramic composition and structure on in vitro behaviour. II. Precipita-tion. J Biomed Mater Res 1993; 27(1): 35‒45.
Sun L, Berndt CC, Gross KA, Kucuk A. Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: a review. J Biomed Mater Res 2001; 58(5): 570‒92.
Mozayeni MA, Milani AS, Marvasti LA, Asgary S. Cytotoxicity of calcium enriched mixture cement compared with mineral trioxide aggregate and intermediate restorative material. Aust Endod J 2012; 38(2): 70‒5.
Dianat O, Azadnia S, Mozayeni MA. Toxicity of calcium hy-drox¬ide nanoparticles on murine fibroblast cell line. Iran En-dod J 2015; 10(1): 49‒54.
Zhao X, Ng S, Heng BC, Guo J, Ma L, Tan TT et al. Cytotoxici-ty of hydroxyapatite nanoparticles is shape and cell dependent. Arch Toxicol 2013; 87(6): 1037‒52.
